Fiduciary Services Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$4.26M Buy
72,795
+37,617
+107% +$2.27M 1.4% 17
2014
Q4
$2.3M Sell
35,178
-260
-0.7% -$16.4K 0.79% 43
2014
Q3
$2.05M Sell
35,438
-414
-1% -$23K 0.75% 46
2014
Q2
$2.02M Buy
35,852
+1,298
+4% +$68.1K 0.76% 45
2014
Q1
$1.78M Buy
34,554
+450
+1% +$22.7K 0.71% 47
2013
Q4
$1.8M Sell
34,104
-2,795
-8% -$137K 0.72% 48
2013
Q3
$1.65M Buy
36,899
+10
+0% +$443 0.73% 50
2013
Q2
$1.52M Buy
+36,889
New +$1.61M 0.68% 52

Other funds holding ABBV

Fiduciary Services Corp's ABBV Position: Q1 2015 in Review

Fiduciary Services Corp increased its AbbVie (ABBV) stake by 107% in Q1 2015, buying an estimated $2.27M and bringing the position to 72,795 shares worth $4.26M. The position accounts for 1.4% of the portfolio, ranked #17.

Fiduciary Services Corp first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. 1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

  • Fiduciary Services Corp held 72,795 shares of AbbVie worth $4.26M as of Q1 2015.
  • Fiduciary Services Corp bought 37,617 AbbVie shares in Q1 2015, an estimated $2.27M.
  • AbbVie made up 1.4% of Fiduciary Services Corp's portfolio in Q1 2015, its #17 holding.
  • Fiduciary Services Corp first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
  • 1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Fiduciary Services Corp's 13F filing for Q1 2015, filed 14 May 2015.